Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Matern Fetal Neonatal Med. 2012 Nov 23;26(4):327–338. doi: 10.3109/14767058.2012.735724

Figure 4. IL-33 and IL1RL1 (ST2) mRNA expression in amnion mesenchymal cells.

Figure 4

(A) Amnion mesenchymal cells (AMCs) treated with IL-1β expressed significantly increased IL-33 mRNA (p<0.001 for both 1 ng/ml and 10 ng/ml) and significantly decreased IL1RL1 (ST2) mRNA (p=0.007 for 1 ng/ml and p=0.003 for 10 ng/ml). (B) IL-33 and IL1RL1 (ST2) mRNA expression did not change in AMCs treated with CXCL10 (p>0.05 for both concentrations).